A NEW FACE OF ENDOCANNABINOIDS IN PHARMACOTHERAPY PART II. ROLE OF ENDOCANNABINOIDS IN INFLAMMATION-DERIVED CARDIOVASCULAR DISEASES

Erstveröffentlichung
2014Authors
Zubrzycki, Marek
Liebold, Andreas
Janecka, Anna
Zubrzycka, Maria
Wissenschaftlicher Artikel
Published in
Journal of physiology and pharmacology ; 65 (2014), 2. - S. 183-191. - ISSN 0867-5910
Institutions
UKU. Klinik für Herz-, Thorax- und GefäßchirurgieSubject headings
[Free subject headings]: endocannabinoid system | cardiovascular system | atherosclerosis | restenosis | diabetic cardiomyopathy | CANNABINOID RECEPTOR CB2 | MUSCLE-CELL PROLIFERATION | CORONARY-ARTERY-DISEASE | GLYCATION END-PRODUCTS | OXIDATIVE STRESS | CARDIAC DYSFUNCTION | METABOLIC SYNDROME | abdominal obesity | ELUTING STENTS | DIABETIC HEART[DDC subject group]: DDC 610 / Medicine & health